Reneo Pharmaceuticals (RPHM) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

Reneo Pharmaceuticals Revenue Highlights


00

Reneo Pharmaceuticals Revenue by Period


Reneo Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Reneo Pharmaceuticals generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Reneo Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$734.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Reneo Pharmaceuticals generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Reneo Pharmaceuticals Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
RPRXRoyalty Pharma$2.35B$567.98M
APLSApellis Pharmaceuticals$366.28M$179.14M
LEGNLegend Biotech$285.14M$93.99M
DNAGinkgo Bioworks$251.46M$56.21M
ADPTAdaptive Bio$170.28M$43.19M
VIRVir Bio$86.18M$3.08M
HOWLWerewolf Therapeutics$19.94M$742.00K
KZRKezar Life Sciences$7.00M-
KRONKronos Bio$6.29M$2.69M
CGEMCullinan Oncology--
CCCCC4 Therapeutics--
AVROAVROBIO--
CNSPCNS Pharmaceuticals--
NKTXNkarta--
PRMEPrime Medicine--
DBTXDecibel Therapeutics--
SMMTSummit Therapeutics--
CELCCelcuity--
OCEAOcean Biomedical--
IMMXImmix Biopharma--
EWTXEdgewise Therapeutics--
HEPAHepion Pharmaceuticals--
RPHMReneo Pharmaceuticals--

RPHM Revenue FAQ


Reneo Pharmaceuticals's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. RPHM's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

Reneo Pharmaceuticals's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). RPHM's quarterly revenue for Q4 2023 was $734K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

Reneo Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.